Company intelligence / Profile preview

RZ Capital

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

RZ Capital is a private investment firm and family office based in Israel, primarily managing the assets of the Zisapel family, founders of the RAD-Bynet Group. The firm has a significant focus on the life sciences, biotechnology, and healthcare sectors, providing capital and strategic guidance to innovative companies. RZ Capital invests across various stages of development, from early-stage startups to mature companies, with a portfolio that includes therapeutics, medical devices, and digital health solutions. Notable investments include companies such as Neurim Pharmaceuticals and BioLineRx, reflecting their commitment to advancing medical innovation in Israel and globally.

Industry: Investors

Beyond the preview

Go deeper on RZ Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RZ Capital.

Explore the full profile